A strategic maneuver from the titan of mRNA vaccine technology has shifted a potentially life-changing therapy for a rare disease into the hands of a specialized pharmaceutical firm, signaling a significant recalibration of priorities for both companies. In a deal that highlights the complex
A pivotal study in precision oncology is poised to reshape how clinicians approach cancers driven by specific genetic alterations, offering a detailed roadmap for identifying and treating mutations that have long been underrecognized. Led by Dr. Wei Yang and his team, the research introduces a
A groundbreaking personalized cancer therapy that essentially teaches a patient's own immune system how to recognize and destroy their specific tumor has delivered remarkable results in its initial human trial, signaling a potential new era in the fight against advanced solid tumors. This
A recent clinical trial has successfully demonstrated that treating a rare and aggressive skin cancer with immunotherapy before surgery can completely eliminate tumors in the majority of patients, heralding a profound shift in how this formidable disease is managed. The groundbreaking research,
The intricate connection between what we eat and how we feel extends far beyond calories and vitamins, reaching into the complex world of hormones naturally present in our daily meals. While widely recognized as the body's sleep regulator, melatonin is emerging from the shadows of the circadian
We're joined today by Ivan Kairatov, a biopharma expert whose work at the intersection of technology and R&D provides a unique lens on the future of oncology. While immune checkpoint inhibitors have revolutionized cancer treatment, the stark reality is that most patients don't respond, largely due
